1. Home/
  2. Compounds/
  3. SNX-2112:bortezomib (250:1 mol/mol)

SNX-2112:bortezomib (250:1 mol/mol)

Synonyms

SourcesNames Used
CTRPv2SNX-2112:bortezomib (250:1 mol/mol)
PharmacoGx SNX-2112:bortezomib (250:1 mol/mol)

FDA Approval Status

Not Approved
Dataset Select
Download Data as CSV

Top molecular features associated with response to SNX-2112:bortezomib (250:1 mol/mol)


Feature TypeStandardized
Nominal ANOVA
mRNA KHDRBS1 CTRPv2 pan-cancer AAC 0.18 2e-07
mRNA EXOSC9 CTRPv2 pan-cancer AAC 0.18 3e-07
mRNA TIMP2 CTRPv2 pan-cancer AAC -0.2 3e-07
mRNA SRSF1 CTRPv2 pan-cancer AAC 0.17 3e-07
mRNA ADAT2 CTRPv2 pan-cancer AAC 0.19 4e-07
mRNA ARHGAP19 CTRPv2 pan-cancer AAC 0.21 4e-07
mRNA ZBTB4 CTRPv2 pan-cancer AAC -0.18 5e-07
mRNA CTSA CTRPv2 pan-cancer AAC -0.18 6e-07
mRNA B4GALT7 CTRPv2 pan-cancer AAC -0.17 6e-07
mRNA ELAVL1 CTRPv2 pan-cancer AAC 0.18 6e-07
Download CSV